VERU DENNISON T 4
4 · Brickell Biotech, Inc. · Filed Jul 2, 2020
Insider Transaction Report
Form 4
VERU DENNISON T
Director
Transactions
- Exercise/Conversion
Common Stock
2020-06-30+787→ 958,813 total(indirect: By Self due to Control over the Entity that holds Shares) - Exercise/Conversion
Restricted Stock Units
2020-06-30−787→ 1,575 total(indirect: By self due to Control over the Entity that holds RSUs)→ Common Stock (787 underlying)
Holdings
- 26,872
Common Stock
Footnotes (3)
- [F1]Restricted stock units ("RSUs") converted into common stock on a one-for-one basis.
- [F2]These RSUs were granted on February 14, 2020 and vest in installments through August 31, 2020.
- [F3]The reporting person filed a Form 4 on June 5, 2020 which reported, among other transactions, the vesting on various dates of portions of a grant of RSUs made on February 14, 2020. Column 9 of Table II of that Form 4 incorrectly reported the number of unvested RSUs remaining from that grant following each such vesting. The number reported in this Column 9 of Table II of this Form 4 represents the correct number of unvested RSUs remaining from the February 14, 2020 grant following the vestings that were reported on the Form 4 filed on June 5, 2020, as well as the vesting that occurred on June 30, 2020 as reported on this Form 4.